health

Alzheimer’s drugs ‘make no meaningful difference to patients’, say researchers

By
1 Mins read
50
0
Share
Reading Time: < 1 minute

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s (Alamy/PA) -

Drugs that are said to slow the progression of Alzheimer’s disease “make no meaningful difference to patients” while increasing the risk of swelling and bleeding  Read More

50
0
Share
Related posts
health

Nine foreign nationals killed in Indian hotel fire

By
1 Mins read
Reading Time: < 1 minuteA fire tore through a hotel in India’s eastern city of Kolkata, killing at least nine people including a child, the latest…
health

Hundreds of women in France accuse civil servant of drugging them

By
1 Mins read
Reading Time: < 1 minuteThe alleged victims of a civil servant accused of drugging hundreds of women to make them urinate have spoken out about their…
health

Liberia says it's taking in 1,200 third-country US deportees

By
1 Mins read
Reading Time: < 1 minuteLiberia has agreed to accept up to 1,200 third-country deportees from the United States in the next 12 months, the government said…
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.